These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 19891689

  • 21. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions.
    Couppié P, Clyti E, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R.
    Am J Trop Med Hyg; 2004 Nov; 71(5):558-60. PubMed ID: 15569784
    [Abstract] [Full Text] [Related]

  • 22. Treatment of leishmaniasis with miltefosine: 2008 status.
    Berman JJ.
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine.
    Botelho AC, Mayrink W, Oliveira RC.
    Acta Trop; 2009 Nov; 112(2):143-8. PubMed ID: 19631187
    [Abstract] [Full Text] [Related]

  • 27. Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis.
    Morelli P, Gianelli E, Calattini S, Corbellino M, Antinori S, Meroni L.
    J Travel Med; 2004 Nov; 11(5):328-30. PubMed ID: 15544717
    [No Abstract] [Full Text] [Related]

  • 28. Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis.
    Ansari NA, Ramesh V, Salotra P.
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1160-2. PubMed ID: 18639311
    [Abstract] [Full Text] [Related]

  • 29. Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
    Yébenes M, Cruz I, Cañavate C, Gilaberte M, Baena V, Pujol RM.
    Clin Exp Dermatol; 2008 Mar; 33(2):142-4. PubMed ID: 18076691
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Cutaneous leishmaniasis due to Leishmania major involving the bone marrow in an AIDS patient in Burkina Faso].
    Barro-Traoré F, Preney L, Traoré A, Darie H, Tapsoba P, Bassolé A, Sawadogo S, Niamba P, Grosshans E, Geniaux M.
    Ann Dermatol Venereol; 2008 May; 135(5):380-3. PubMed ID: 18457724
    [Abstract] [Full Text] [Related]

  • 32. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS, Tuon FF, Imamura R, Abegão de Camargo R, Duarte MI, Neto VA.
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cutaneous leishmaniasis. Treatment with itraconazole.
    Albanese G, Giorgetti P, Santagostino L, Crippa D, Sala G.
    Arch Dermatol; 1989 Nov; 125(11):1540-2. PubMed ID: 2554818
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [A Pediatric case of lupoid leishmaniasis diagnosed by PCR].
    Paradisi M, Grosso MG, Angelo C, Gradoni L, Ludovisi A, N'Doni F, Puddu P.
    Minerva Pediatr; 2001 Feb; 53(1):33-7. PubMed ID: 11419394
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.